LCGC North America
The authors describe a sensible approach for validation and implementation of HPLC IPC assays.
Determining the Link Between Prenatal Cannabis Use and Symptoms of Depression Using LC–MS/MS
April 16th 2025Researchers investigating the relationship between cannabis use during pregnancy and depressive symptoms—and whether continued use beyond the first trimester or higher levels of use were linked to increased symptoms—used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to confirm the presence of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH) in urine samples.
A Guide to (U)HPLC Column Selection for Protein Analysis
April 16th 2025Analytical scientists are faced with the task of finding the right column from an almost unmanageable range of products. This paper focuses on columns that enable protein analysis under native conditions through size exclusion, hydrophobic interaction, and ion exchange chromatography. It will highlight the different column characteristics—pore size, particle size, base matrices, column dimensions, ligands—and which questions will help decide which columns to use.
Common Challenges in Nitrosamine Analysis: An LCGC International Peer Exchange
April 15th 2025A recent roundtable discussion featuring Aloka Srinivasan of Raaha, Mayank Bhanti of the United States Pharmacopeia (USP), and Amber Burch of Purisys discussed the challenges surrounding nitrosamine analysis in pharmaceuticals.